Previous Close | 0.3300 |
Open | 1.8000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 16.00 |
Expire Date | 2024-07-19 |
Day's Range | 1.7000 - 1.8000 |
Contract Range | N/A |
Volume | |
Open Interest | 17 |
Marinus Pharmaceuticals, Inc. ( NASDAQ:MRNS ) just released its latest first-quarter report and things are not looking...
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 0% and 10.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RADNOR, Pa., May 08, 2024--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the first quarter ended March 31, 2024.